Adjuvant capecitabine plus oxaliplatin after D2 gastrectomy in Japanese patients with gastric cancer: a phase II study

BACKGROUND: Adjuvant chemotherapy with XELOX (capecitabine plus oxaliplatin) has been shown to be beneficial following resection of gastric cancer in South Korean, Chinese, and Taiwanese patients. This phase II study (J-CLASSIC-PII) was undertaken to evaluate the feasibility of XELOX in Japanese pat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Gastric Cancer
Autors principals: Fuse, Nozomu, Bando, Hideaki, Chin, Keisho, Ito, Seiji, Yoshikawa, Takaki, Tsuburaya, Akira, Terashima, Masanori, Kawashima, Yoshiyuki, Fukunaga, Tetsu, Gotoh, Masahiro, Emi, Yasunori, Yoshida, Kazuhiro, Oki, Eiji, Takahashi, Seiji, Kuriki, Hiroshi, Sato, Kumi, Sasako, Mitsuru
Format: Artigo
Idioma:Inglês
Publicat: Springer Japan 2016
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5321693/
https://ncbi.nlm.nih.gov/pubmed/26956689
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10120-016-0606-4
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars